Showing results (141-150 of 159) with videos related to
Sort By:
Pageof 16
Addiction (Abingdon, England)|May 5, 2021
Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysisSean M Murphy, Philip J Jeng, Kathryn E McCollister, et al.BMJ (Clinical Research Ed.)|October 18, 2003
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trialLeif Bjermer, Hans Bisgaard, Jean Bousquet, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluationBruce R Schackman, Jared A Leff, Michael Botsko, et al.Thorax|March 4, 2003
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthmaD B Price, D Hernandez, P Magyar, et al.Drug and Alcohol Dependence|August 11, 2020
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trialAli Jalali, Danielle A Ryan, Philip J Jeng, et al.The Journal of Pediatrics|May 9, 2001
Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover studyF E Simons, J R Villa, B W Lee, et al.Annals of the American Thoracic Society|August 29, 2014
Open-access biorepository for idiopathic pulmonary fibrosis. The way forwardEric S White, Kevin K Brown, Harold R Collard, et al.AIDS (London, England)|March 28, 2014
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patientsBenjamin P Linas, Devra M Barter, Jared A Leff, et al.Addiction Science & Clinical Practice|November 15, 2018
Closing the gaps in opioid use disorder research, policy and practice: conference proceedingsMatthew A Miclette, Jared A Leff, Isabella Cuan, et al.Substance Abuse Treatment, Prevention, and Policy|April 9, 2021
Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder researchMichelle A Papp, Jared A Leff, Sean M Murphy, et al.Pageof 16